Virus |
Target |
Vector/Delivery |
Immunization |
Response |
Reference |
BVDV |
NS3 (p80) |
SFV / DNA
|
Mouse |
CTL, CMI |
[63] |
CSFV |
E2 |
SFV / DNA |
Swine
|
CSFV protection |
[24] |
EAV |
G, L, M |
VEE /Particles |
Mouse |
Neutralizing Abs |
[64] |
Ebola
|
NP
NP, GP
VP24, 30, 35, |
VEE /Particles
VEE /Particles
VEE /Particles |
Mouse
Mouse
Mouse |
Ebola protection
Ebola protection Ebolaprotection |
[18]
[65]
[66] |
Hepatitis B |
cAg
sAg |
SIN / DNA
SIN / DNA |
Guinea pig
Mouse |
Specifi c Abs
Specifi c Abs |
[67]
[67] |
Hepatitis C |
cAg
NS3
|
SFV/Particles,DNA SFV / Particles |
Mouse
Mouse |
CTL
Cellular |
[68]
[69] |
HeV |
Glycoprotein |
VEE / Particles |
Mouse |
Neutralizing Abs |
[25] |
HIV-1 |
env
gp41
MA/CA |
SFV / Particles
SFV / Particles
VEE / Particles |
Mouse
Mouse
Mouse |
Humoral
Monoclonal Abs
Humoral, CTL |
[15]
[16]
[17] |
HPV |
16E7
16E7-VP22
E7-hsp70 |
SFV / DNA
SIN / Particles
SIN / Particles |
Mouse
Mouse
Mouse |
CTL
CD8+ T cell response
CTL |
[70]
[71]
[72] |
HSV-1 |
gpB |
SIN / Particles |
Mouse |
HSV protection |
[73] |
|
gpB |
SIN / DNA |
Mouse |
CTL, protection |
[74] |
IBDV |
VP2 |
SFV / Particles, DNA |
Chicken |
Specific Abs |
[75] |
Influenza |
HA |
SFV / Particles |
Mouse |
Systemic response |
[13] |
|
HA |
SFV / DNA |
Mouse |
Humoral, cellular |
[76] |
|
HA |
VEE / Particles |
Chicken |
Influenza protection |
[14] |
|
HA |
VEE / Particles |
Swine |
Influenza protection |
[20] |
|
HA |
VEE / Particles |
Swine |
Specific Abs |
[21] |
|
NP |
SFV / Particles, RNA |
Mouse |
Humoral, CTL |
[77] |
|
NP |
SFV / Particles, RNA |
Mouse |
CTL |
[78] |
JEV |
prM-E, NS1-2A |
SIN / Particles |
Mouse |
JEV Abs |
[79] |
Lassa |
N |
VEE / Particles |
Mouse |
Immune response |
[19] |
LIV |
prME
prME, NS1 |
SFV / Particles
SFV / Particles |
Mouse
Sheep |
LIV protection
LIV protection |
[80]
[81] |
MBGV |
GP, NP, VP35
GP, NP |
VEE / Particles
VEE / Particles |
Guinea pig
Macaques |
MBGV protection
MBGV protection |
[82]
[83] |
Measles |
HA, FUd
HA, FUd |
SIN / DNA
SIN-VEE / Particles |
Mouse
Macaques |
Measles protection
Measles protection |
[29]
[30] |
MVE |
prME, E |
SFV / Particles |
Mouse |
Neutralizing Abs |
[84] |
NiV |
Glycoproteins |
VEE / Particles |
Mouse |
Neutralizing Abs |
[25] |
NLV |
VLP |
VEE / Particles |
Mouse |
Immune response |
[85] |
Rabies |
G |
SIN / DNA |
Mouse |
Rabies protection |
[32] |
RSV |
F, G
F, G |
SFV / DNA, RNA SFV / Particles |
Mouse
Mouse |
RSV protection
RSV protection |
[86]
[87] |
SARS-CoV |
Glycoprotein |
VEE / Particles |
Mouse |
SARS-CoV protection |
[23] |
SEOV |
M, S |
SIN /Particles, DNA |
Hamster |
SEOV protection |
[88] |
SHIV |
env |
SFV / Particles |
Macaques |
T cell prolif. Response |
[89] |
Vaccinia |
A33R, B5R |
VEE / Particles |
Mouse |
Vaccinia protection |
[31] |
Abs: Antibodies; BVDV: Bovine viral diarrhea virus; CMI: Cell-mediated immune response; CSFV: Classical swine fever virus; CTL: Cytotoxic T-lymphocyte activity; EAV:
Equine arteritis virus; HBV: Hepatitis B virus; HBC: Hepatitis C virus; HeV: Hendra virus; HIV: Human immunodeficiency virus; HPV: Human papillomavirus; HSV: Herpes
simplex virus; IBDV: Infectious bursal disease virus; JEV: Japanese encephalitis virus; LIV: Loupin ill virus; MBGV: Marburg virus; MVE: Murray Valley encephalitis virus;
NiV: Nipah virus; NLV: Norwalk-like virus; RSV: Respiratory syncytial virus; SARS-CoV: Severe acute respiratory syndrome corona virus; SEOV: Seoul virus; SFV: Semliki
Forest virus; SHIV: Simian-human immunodeficiency virus; SIN: Sindbis virus; VEE: Venezuelan equine encephalitis virus |
